September 29, 2025
 
 
RedChip Logo
Small Stocks, Big Money™
Weekly Newsletter
REDCHIP.COM
 
Feature News
 
BullFrog AI Launches Global Sales of BullFrog Data Networks™ with Sygnature Discovery, Targeting Up to $30M Revenue Opportunity
 
BullFrog AI (Nasdaq: BFRG) has officially kicked off commercial sales of its BullFrog Data Networks™ platform through a global partnership with Sygnature Discovery. With a projected revenue opportunity of $15–$30 million through 2028, the AI-powered solution is now being marketed to Sygnature’s extensive biopharma client base, offering cutting-edge tools for early target discovery, clinical trial optimization, and data-driven drug development.
 
 
 
 
 
 
 
 
 
New Era Energy Hits Major Milestone with Phase One Completion at 1GW AI Data Center Campus
 
New Era Energy & Digital (Nasdaq: NUAI) has completed Phase One engineering for its flagship AI-focused data center project in the Permian Basin, a 1-gigawatt campus developed through its 50/50 JV with Sharon AI. Backed by environmental clearances and feasibility validations, the project is on track for power delivery in early 2027—positioning New Era to meet the explosive demand for AI infrastructure with a vertically integrated model that lowers tenant costs and accelerates deployment.
 
 
 
 
 
 
 
Jackpot Digital Secures Mississippi Gaming License, Expanding U.S. Footprint
 
Jackpot Digital (OTCQB: JPOTF; TSXV: JJ) has been granted a Manufacturer and Distributor License by the Mississippi Gaming Commission, paving the way for deployment of its flagship dealerless poker platform, Jackpot Blitz®, across the $2.4B Mississippi gaming market. This marks the company’s second U.S. state-level license and signals accelerating adoption of its digital poker tables by leading land-based casinos in one of the nation’s top gaming destinations.
 
 
 
 
 
 
 
 
 
NioCorp Prices $60M U.S. Public Offering to Advance Elk Creek Critical Minerals Project
 
NioCorp Developments (Nasdaq: NB) has priced a $60 million public offering of common shares at $6.15 per share, with proceeds earmarked to support working capital and move its Elk Creek Project toward construction and commercial operation. Positioned to produce high-value critical minerals like niobium, scandium, titanium, and rare earths, the Elk Creek Project is a cornerstone in NioCorp’s strategy to address rising global demand for strategic materials.
 
 
 
 
 
 
 
Phoenix Motor Expands Crypto Payments and Launches Treasury Plan to Boost EV Sales & Digital Integration
 
Phoenix Motor (OTC: PEVM) has expanded its EdisonFuture subsidiary’s payment options to include Ethereum, BNB, and Solana, alongside Bitcoin, and unveiled a crypto treasury management strategy to optimize digital asset use. This move enhances flexibility for electric vehicle and EFaaS customers while positioning Phoenix at the forefront of fintech integration in the zero-emission commercial transport space.
 
 
 
 
 
Recent News
 
 
 
 
 
 
 
 
 
 
RedChip TV
 
 
 
 
RedChip Highlights Foremost Clean Energy Ltd. (NASDAQ: FMST)& Aptevo Therapeutics Inc.(NASDAQ: APVO)
 
 
 
 
 
 
 
RedChat Ad
 
 
Unlock Smarter Investing with RedChat
RedChat Ad
Tired of sifting through endless filings? Let RedChat do the heavy lifting. Get real-time, data-driven insights on over 2,000 small-cap stocks—instantly. Save time, make informed decisions, and stay ahead of the market.
Access RedChat now, free of charge.
START USING REDCHAT
 
Recent Research Coverage Updates
 
Company Rating Price Target Firm Report Date
Greenwich LifeSciences (Nasdaq: GLSI) Buy $45 Noble August 20, 2025
Atossa Therapeutics (Nasdaq: ATOS) Buy $7 HC Waingwright August 12, 2025
Atossa Therapeutics (Nasdaq: ATOS) Buy $4 Maxim August 12, 2025
Atossa Therapeutics (Nasdaq: ATOS) Buy $4 Maxim August 12, 2025
FibroBiologics (Nasdaq: FBLG) Buy $16 D Boral July 29, 2025
Connect Biopharma (Nasdaq: CNTB) Buy $7.5 Northland Securities July 23, 2025
Connect Biopharma (Nasdaq: CNTB) Buy $4 Titan Partners July 17, 2025
NioCorp (Nasdaq: NB) Buy $5 Maxim July 10, 2025
Connect Biopharma (Nasdaq: CNTB) Buy $7 H.C. Wainwright July 9, 2025
FibroBiologics (Nasdaq: FBLG) Buy $16 D Boral July 9, 2025
NioCorp (Nasdaq: NB) Buy $4 HC Wainwright July 2, 2025
Alliance Entertainment (Nasdaq: AENT) Buy $10 Maxim July 1, 2025
Lantern Pharma (Nasdaq: LTRN) Buy $25 Lake Street June 17, 2025
Atossa Therapeutics (Nasdaq: ATOS) Buy $4 Craig Hallum June 5, 2025
Creative Medical (Nasdaq: CELZ) Buy $8 Roth June 4, 2025
Alliance Entertainment (Nasdaq: AENT) Buy $8 ThinkEquity June 2, 2025
Atossa Therapeutics (Nasdaq: ATOS) Buy $7.25 Ascendiant Capital April 20, 2025
Enlivex Therapeutics (NASDAQ: ENLV) Buy $7 H.C. Wainwright March 24, 2025
BioVie (Nasdaq: BIVI) Buy $6 Brookline March 18, 2025
Lantern Pharma (Nasdaq: LTRN) Buy $15 ThinkEquity March 17, 2025
Jupiter Neurosciences (Nasdaq: JUNS) Buy $30 Greenridge Global March 6, 2025
Fathom Holdings (NASDAQ: FTHM) Buy $3.75 Roth March 3, 2025
XORTX Therapeutics (Nasdaq: XRTX) Buy $14 AGP February 25, 2025
Enlivex Therapeutics (NASDAQ: ENLV) Buy $13 D. Boral February 7, 2025
Gorilla Technology Group (NASDAQ: GRRR) Buy $18 Northland Capital Markets January 22, 2025
Gorilla Technology Group (NASDAQ: GRRR) Buy $3 ThinkEquity January 13, 2025
Gorilla Technology Group (NASDAQ: GRRR) Buy $27 Alliance Global Partners January 2, 2025
 
 
 
Podcast Logo
Small Stocks, Big Money™ Podcast
The podcast features in-depth interviews with CEO's from the top names in small-cap stocks, providing listeners with a unique perspective not found anywhere else.
Available on:
Amazon Music Apple Podcasts Spotify
LEARN MORE
 
 
Upcoming Events
 
 
30
 
 
SEPT 2025
 
Enlivex Therapeutics (NASDAQ: ENLV)
10:00am Eastern
 
Join Jason Kolbert, Managing Director of Healthcare Research at D. Boral Capital and Dr. Roger Pomerantz, M.D. & Vice Chairman of Enlivex Therapeutics for an exclusive virtual panel discussion featuring Professor Philip Conaghan MBBS, PhD, FRACP, FRCP, a leading clinician scientist working in the field of musculoskeletal medicine and Professor Ali Mobasheri BSc, ARCS, MSc, DPhil (Oxon), a leading scientist working in the area of musculoskeletal biology.
 
 
 
 
 
 
 
8
 
 
OCT 2025
 
BioVie (NASDAQ: BIVI)
4:15pm Eastern
 
BioVie Inc. (NASDAQ: BIVI) is a clinical-stage company developing innovative drug therapies for the treatment of neurological and neurodegenerative disorders (Alzheimer's disease, Parkinson’s disease and long COVID) and advanced liver disease. In neurodegenerative disease, the Company’s lead drug candidate bezisterim inhibits the production of tumor necrosis factor alpha (TNF-α) to reduce neuroinflammation and insulin resistance – both of which are drivers of Alzheimer’s and Parkinson’s.
 
 
 
 
 
 
 
Archived Events
 
 
24
 
 
SEPT 2025
 
NioCorp Developments (NASDAQ: NB)
4:15pm Eastern
 
NioCorp is developing the Elk Creek Project that is expected to produce niobium, scandium, and titanium.
 
 
 
 
 
 
 
 
Quote of the Week
 
"Our approach to investing in small- and micro-cap companies is successful because it focuses on what matters when trying to value individual companies within the context of ever-changing investor tastes: seeing past the noise of what is popular at the moment and identifying value with independent judgment."
— Punch & Associates Investment Management Inc
 
 
Order "Small Stocks, Big Money™ Today!
 
Dave Gentry's new book, Small Stocks, Big Money: Interviews With Microcap Superstars, is now available for pre-order. Published by Wiley Finance, this first-hand perspective and insider information on the fast world of microcap investing is now available for purchase.
 
 
 
 
 
 
 
Lesson of the Week
 
Mitigate risk in small-caps by buying a basket of stocks.